|
|
|
Cardiovascular diseases market in China
|
|
|
| Anglais,
PDF, Janvier 2003, 21 pages
|
|
|
|
|
|
| Secteur analysés : |
statins,cardiovascular diseases,cancer
|
| Type d'analyse : |
market outlook,industry structure |
| Marché traités : |
china,pakistan,india,indonesia,malaysia,uruguay,... |
| |
|
|
|
|
|
|
|
|
| |
 |
|
|
| |
 |
Email: |
|
Choisissez un mot de passe: |
|
Confirmez votre mot de passe: |
|
|
|
|
|
|
| |
|
|
|
| asthma,
cancer,
cardiovascular diseases,
generics,
rice,
statins,
|
| world health organization department of chronic diseases and promotion global initiative for treatment major shanthi mendis md frcp facc coordinator cardiovascular rationale objectives processes activities expected outcomes mortality cvd 16 7 million diabetes 0 98 crd 3 cancer 42 ncd burden number deaths projected to 2020 2002 2000000 4000000 6000000 8000000 10000000 12000000 14000000 16000000 18000000 20000000 lower income higher millions the potential secondary prevention rr reduction 2 year event rate none 8 aspirin 25 6 b 4 5 statin 30 acei euroaspire survey overall percentage on rx 63 43 84 66 02040608010 statins bb lancet 2001 357 996 1001 drugs |
|
|
| >> Marché Environnement en France >> |
DPLSEN |
|
|
|
|
|
